|
|
Volumn 27, Issue 2, 2006, Pages 225-241
|
|
Using race in clinical research to develop tailored medications: Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFRICAN AMERICAN;
CAUCASIAN;
CLINICAL RESEARCH;
COURT;
DRUG INDUSTRY;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE SYSTEM;
HUMAN;
LAW;
MINORITY GROUP;
RACISM;
REVIEW;
UNITED STATES;
ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DRUG APPROVAL;
DRUG COMBINATION;
ECONOMICS;
ETHNOLOGY;
GENETICS;
JURISPRUDENCE;
LEGAL ASPECT;
PATIENT SELECTION;
PHARMACOGENETICS;
SOCIAL PSYCHOLOGY;
SOCIOECONOMICS;
TREATMENT OUTCOME;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
ISOSORBIDE HYDRALAZINE COMBINATION;
ISOSORBIDE-HYDRALAZINE COMBINATION;
NEW DRUG;
VASODILATOR AGENT;
AFRICAN AMERICANS;
CLINICAL PROTOCOLS;
CLINICAL TRIALS;
DRUG APPROVAL;
DRUG COMBINATIONS;
DRUG INDUSTRY;
DRUGS, INVESTIGATIONAL;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
PATIENT SELECTION;
PHARMACOGENETICS;
PREJUDICE;
SOCIOECONOMIC FACTORS;
SUPREME COURT DECISIONS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VASODILATOR AGENTS;
|
|
EID: 33745958088
PISSN: 01947648
EISSN: 1521057X
Source Type: Journal
DOI: 10.1080/01947640600716457 Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
